Literature DB >> 3919389

Circulating hydroxy fatty acids in familial Mediterranean fever.

P S Aisen, K A Haines, W Given, S B Abramson, M Pras, C Serhan, M Hamberg, B Samuelsson, G Weissmann.   

Abstract

Episodes of fever, serositis, and arthritis in familial Mediterranean fever (FMF) suggested circulating mediators of acute inflammation (e.g., neutrophil activation). The mean serum neutrophil-aggregating activity of 51 FMF patients was 2.5 +/- 0.2 cm2/min, compared to 1.0 +/- 0.1 cm2/min in 20 normal controls (P less than 0.0002). Lipid extracts of FMF sera retained neutrophil-aggregating activity and had UV absorbance peaks at 269 and 279 nm, indicating the presence of lipids with a conjugated triene structure. Chromatography of extracts yielded peaks that were coeluted with reference dihydroxyicosatetraenoic acids, had UV absorbance peaks at 259, 269, and 279 nm, and possessed neutrophil-aggregating activity. The presence of leukotriene B4 was excluded by chromatography following methyl-esterification. Monohydroxy compounds identified in FMF extracts by gas chromatography/mass spectrometry included 5-hydroxyicosatetraenoic acid, and 9- and 13-hydroxyoctadecadienoic acids. Hydroxy acids were present in 19 of 31 FMF sera and absent in extracts of sera from 8 patients with active systemic lupus erythematosus, 7 with fever from infection, and 12 normal controls. The finding of circulating mono- and dihydroxy fatty acids in FMF suggests that defects in the formation or elimination of these compounds might play a role in the pathogenesis of FMF.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919389      PMCID: PMC397229          DOI: 10.1073/pnas.82.4.1232

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Decomposition of unsaturated fatty acid hydroperoxides by hemoglobin: Structures of major products of 13L-hydroperoxy-9,11-octadecadienoic acid.

Authors:  M Hamberg
Journal:  Lipids       Date:  1975-02       Impact factor: 1.880

2.  Benign paroxysmal peritonitis; surgical and histologic findings.

Authors:  I B BRICK; M CAJIGAS
Journal:  N Engl J Med       Date:  1951-05-24       Impact factor: 91.245

3.  Colchicine therapy for familial mediterranean fever. A double-blind trial.

Authors:  C A Dinarello; S M Wolff; S E Goldfinger; D C Dale; D W Alling
Journal:  N Engl J Med       Date:  1974-10-31       Impact factor: 91.245

4.  A controlled trial of colchicine in preventing attacks of familial mediterranean fever.

Authors:  D Zemer; M Revach; M Pras; B Modan; S Schor; E Sohar; J Gafni
Journal:  N Engl J Med       Date:  1974-10-31       Impact factor: 91.245

5.  Lysosomal enzyme release from human leukocytes: mediation by the alternate pathway of complement activation.

Authors:  I M Goldstein; M Brai; A G Osler; G Weissmann
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

Review 6.  Familial Mediterranean fever. A survey of 470 cases and review of the literature.

Authors:  E Sohar; J Gafni; M Pras; H Heller
Journal:  Am J Med       Date:  1967-08       Impact factor: 4.965

7.  Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever.

Authors:  C A Dinarello; M J Chusid; A S Fauci; J I Gallin; D C Dale; S M Wolff
Journal:  Arthritis Rheum       Date:  1976 May-Jun

8.  Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases.

Authors:  P Borgeat; M Hamberg; B Samuelsson
Journal:  J Biol Chem       Date:  1976-12-25       Impact factor: 5.157

9.  Leukocyte function in familial Mediterranean fever.

Authors:  M C Territo; R S Peters; M J Cline
Journal:  Am J Hematol       Date:  1976       Impact factor: 10.047

10.  The regulatory role of divalent cations in human granulocyte chemotaxis. Evidence for an association between calcium exchanges and microtubule assembly.

Authors:  J I Gallin; A S Rosenthal
Journal:  J Cell Biol       Date:  1974-09       Impact factor: 10.539

View more
  7 in total

1.  Recurrent hereditary polyserositis.

Authors:  G C Cook
Journal:  BMJ       Date:  1990-11-17

2.  Hyperactive polymorphonuclear leucocytes migration in patients with Familial Mediterranean Fever.

Authors:  P Disdier; C Fossat; V Veit; M David; L Swiader; J R Harle; I Juhan-Vague; P J Weiller
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

3.  Production of arachidonic and linoleic acid metabolites by guinea pig tracheal epithelial cells.

Authors:  M J Oosthuizen; F Engels; B Van Esch; P A Henricks; F P Nijkamp
Journal:  Inflammation       Date:  1990-08       Impact factor: 4.092

Review 4.  Familial Mediterranean fever--an update.

Authors:  S E Goldfinger
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

5.  Baseline Elevations of Leukotriene Metabolites and Altered Plasmalogens Are Prognostic Biomarkers of Plaque Progression in Systemic Lupus Erythematosus.

Authors:  Sahar Baig; Kamala Vanarsa; Huihua Ding; Anto Sam Crosslee Louis Sam Titus; Maureen McMahon; Chandra Mohan
Journal:  Front Cardiovasc Med       Date:  2022-05-16

6.  Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans.

Authors:  Christopher E Ramsden; Amit Ringel; Ariel E Feldstein; Ameer Y Taha; Beth A MacIntosh; Joseph R Hibbeln; Sharon F Majchrzak-Hong; Keturah R Faurot; Stanley I Rapoport; Yewon Cheon; Yoon-Mi Chung; Michael Berk; J Douglas Mann
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2012-09-05       Impact factor: 4.006

Review 7.  Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions.

Authors:  Simon C Dyall; Laurence Balas; Nicolas G Bazan; J Thomas Brenna; Nan Chiang; Felipe da Costa Souza; Jesmond Dalli; Thierry Durand; Jean-Marie Galano; Pamela J Lein; Charles N Serhan; Ameer Y Taha
Journal:  Prog Lipid Res       Date:  2022-05-01       Impact factor: 14.673

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.